Insilico Medicine is a clinical-stage AI-driven biotech company headquartered in Boston and Hong Kong, specializing in transforming drug discovery to extend human productive longevity. The company leverages artificial intelligence to innovate within the biotech sector, reflecting a strong focus on longevity and pharmaceutical development. Its international presence underscores its commitment to advancing AI applications in drug discovery.

‌